|
Volumn 345, Issue 21, 2001, Pages 1573-1575
|
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATINE KINASE;
FIBRINOGEN RECEPTOR ANTAGONIST;
STREPTOKINASE;
TIROFIBAN;
TROPONIN T;
ANTITHROMBOCYTIC AGENT;
CREATINE KINASE MB;
DRUG DERIVATIVE;
FIBRINOGEN RECEPTOR;
ISOENZYME;
TYROSINE;
ACETYLSALICYLIC ACID;
FIBRINOLYTIC AGENT;
HEPARIN;
ACUTE HEART FAILURE;
CLINICAL TRIAL;
CREATINE KINASE BLOOD LEVEL;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
DRUG INFUSION;
DRUG MECHANISM;
ENZYME INHIBITION;
HEALTH CARE COST;
HEART INFARCTION;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
INTERMETHOD COMPARISON;
LETTER;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TREATMENT INDICATION;
TREATMENT OUTCOME;
BLOOD;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
EPIDEMIOLOGY;
MULTIMODALITY CANCER THERAPY;
NOTE;
TRANSLUMINAL CORONARY ANGIOPLASTY;
UNSTABLE ANGINA PECTORIS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
BIAS (EPIDEMIOLOGY);
COMBINED MODALITY THERAPY;
CREATINE KINASE;
CREATINE KINASE, MB FORM;
HUMANS;
ISOENZYMES;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
TYROSINE;
ANGINA, UNSTABLE;
ASPIRIN;
FIBRINOLYTIC AGENTS;
HEPARIN;
|
EID: 0035936011
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200111223452113 Document Type: Letter |
Times cited : (3)
|
References (0)
|